Clinical Trials
42 trialsNCT07522151 2026-05-13
Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3 Recruiting
NCT05771480 2026-04-21
TOURMALINE
AstraZeneca
Phase 3 Active not recruiting
NCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
NCT07366528 2026-01-26
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
Phase 3 Recruiting
NCT03615326 2025-12-11
MK-3475-811
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT03013010 2025-12-08
PREACT
Shanghai Cancer Hospital, China
Phase 3 Completed
NCT05593458 2025-04-09
TACTIC
Zhejiang University
Phase 3 Recruiting
NCT02867839 2024-12-03
RESCUE-GC
Peking University Cancer Hospital & Institute
Phase 3 Terminated
NCT01285557 2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3 Terminated
NCT05144854 2024-09-05
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Ono Pharmaceutical Co., Ltd.
Phase 3 Active not recruiting
NCT06571461 2024-08-27
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT06194734 2024-03-07
A Study of KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT01515748 2023-12-13
PRODIGY
Sanofi
Phase 3 Completed
NCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
NCT05813015 2023-04-14
Study of Comparing of With and Without Sequential Therapy of S-1
Zhejiang University
Phase 3 Recruiting
NCT03801668 2022-01-04
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Huazhong University of Science and Technology
Phase 3 Unknown
NCT03961867 2021-06-01
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT02114359 2020-10-23
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Phase 3 Completed
NCT02813967 2020-09-16
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Zhejiang Cancer Hospital
Phase 3 Completed
NCT04465968 2020-07-10
DEEP_OCEAN
National Cancer Center Hospital East
Phase 3 Not yet recruiting
NCT04135781 2020-03-23
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…¢ Gastric Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT00770874 2019-06-21
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03941561 2019-05-31
S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）
Fudan University
Phase 3 Recruiting
NCT02736552 2019-05-08
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
Fudan University
Phase 3 Withdrawn
NCT02182778 2019-02-21
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Phase 3 Completed
NCT01824459 2019-01-23
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Phase 3 Completed
NCT03475615 2018-03-23
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
Fudan University
Phase 3 Unknown
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT03061058 2017-09-15
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3 Unknown
NCT01795027 2016-10-25
CAPITAL
Sun Yat-sen University
Phase 3 Unknown
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT00602745 2016-05-26
S-1 Pancreas
Sanofi
Phase 3 Terminated
NCT02677597 2016-02-09
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
Fudan University
Phase 3 Unknown
NCT01671449 2015-11-30
SOPP
Asan Medical Center
Phase 3 Completed
NCT02319187 2015-08-03
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
ChineseAMS
Phase 3 Unknown
NCT00677443 2013-06-14
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase 3 Completed
NCT01283217 2013-06-04
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer
Yonsei University
Phase 3 Unknown
NCT00152217 2011-07-07
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00202969 2011-07-07
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00287768 2011-06-28
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 3 Completed
NCT00316745 2007-11-01
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Suspended